| | | Winship's 2019 year-in-review video highlights the opening of the new Phase I Clinical Trials Unit and the Emory Proton Therapy Center; the ground-breaking on the new cancer facility on the Emory University Hospital Midtown campus; and a $9.7 million grant that boosts Winship’s transformational work in lung cancer research. | Watch Video |
| |
| | Study sheds light on immune control of cancer | Winship investigators, including Carey Jansen, Nataliya Prokhnevska, Hadyn Kissick, PhD, and Viraj Master, MD, PhD, collaborated with surgeons to look at how the level of T cell infiltration in tumors can predict post-surgery outcomes. The results, which focused on kidney and other urologic cancers but could apply more broadly, were published Dec. 11 in Nature.
| Read More | |
| | | | Ganetespib evaluated for second-line therapy in lung cancer | Drs. Rathi Pillai and Suresh Ramalingam led an international, Phase III trial of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel for second-line therapy of patients with advanced adenocarcinoma of the lung. The results of the study were published Dec. 12 in the Journal of Clinical Oncology.
| Read More | |
|
| |
| | NEJM-published study evaluates tucatinib for breast cancer | In heavily pretreated patients with HER2-positive metastatic breast cancer, adding tucatinib to trastuzumab and capecitabine resulted in better progression-free survival and overall survival outcomes. The results of the study, co-authored by Elisavet Paplomata, MD, were published Dec. 11 in the New England Journal of Medicine.
| Read More | |
| | | | Emory breaks ground on innovative biomedical research facility | Emory University broke ground Dec. 11 on a state-of-the-art research facility that will focus on innovation, synergy and impact for biomedical research. The new facility, Health Sciences Research Building II (HSRB II), will be built on Haygood Drive beside its sister facility, Health Sciences Research Building I, which opened in 2013.
| Read More | |
|
| |
| | | This December, Winship and the Emory Department of Radiation Oncology celebrate the one-year anniversary of the Emory Proton Therapy Center. Over the course of the past year, hundreds of Winship patients have benefited from this powerful and precise form of radiation therapy. | Read More |
| |
| | Lewis named interim director of Clifton infusion center | Colleen Lewis, NP, will become interim director of the Clifton Campus Winship Ambulatory Infusion Center beginning on Jan. 1. Lewis will continue in her role as director of clinical operations for the Phase I Program at the same time she takes on this new role.
| Read More | |
| | | | Arellano to chair prIME Oncology symposium | Martha Arellano, MD will chair the Hematologic Malignancies Demystified symposium on Jan. 25 at Atlanta's Intercontinental Hotel Buckhead. Expert faculty, including Jonathan Kaufman, MD, will focus on updates from recent congresses and the latest clinically relevant data.
| Register and Learn More | |
|
| |
| | | Winship's 10 shared resources offer advanced technologies and services to support cancer researchers. The Cancer Animal Models Shared Resource specializes in mouse-focused animal model development. Service highlights include GEMM, xenograft, and PDX models; tumor induction and monitoring; optical fluorescent and bioluminescent imaging; drug delivery and tumor measurement; and cranial window surgery. | Learn More |
| |
| | Winship Summer Scholar presents at ASH | High school student Esther Kim (right, with mentor Pamela Allen, MD) presented data that she helped gather as a 2019 Winship Summer Scholars Research Program participant at the recent American Society of Hematology (ASH) annual meeting in Orlando. Applications for the 2020 Summer Scholars Research Program are due Feb. 3.
| Learn More | |
| | | | Call for LOI: Winship K12 training program | The Winship K12 Clinical Oncology Training Program, supported by the National Cancer Institute, provides resources and training to early-career clinician-investigators in the conduct of therapeutic cancer clinical research studies with a focus on Phase I and Phase II clinical trials. Letters of intent (LOI) for the two-year program are due Jan. 10.
| Learn More | |
|
| |
| |
| A selection of media stories and news coverage for Winship Cancer Institute. |
| |
| You are receiving Winship Roundup as a member or employee of Winship Cancer Institute. If you wish to unsubscribe, please email Winship Communications.
Emory Home |
Emory News Center |
Give to Emory |
Contact Emory Have a story for Winship Roundup? Submit your suggestion via email. © 2021 Winship Cancer Institute of Emory University |
1365 Clifton Rd. NE, Bldg. C, Atlanta, Georgia 30322 | |
|